1 / 1

Combined International Multi-Center Phase I and II Study on Safety and Performance of the Ambu Laryngeal Mask ®

Combined International Multi-Center Phase I and II Study on Safety and Performance of the Ambu Laryngeal Mask ®. INTRODUCTION. METHODS. RESULTS.

quade
Download Presentation

Combined International Multi-Center Phase I and II Study on Safety and Performance of the Ambu Laryngeal Mask ®

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Combined International Multi-Center Phase I and II Study on Safety and Performance of the Ambu Laryngeal Mask® INTRODUCTION METHODS RESULTS Since the introduction of the LMA, supraglottic airway devices have become an established tool in airway management.1,2 The Ambu Laryngeal Mask® (Ambu A/S, Ballerup, Denmark) is a new disposable supraglottic airway device similar in design to the LMA-Classic. This multi-center trial was designed to evaluate the performance and safety of the Ambu Laryngeal Mask in elective surgical patients during positive pressure ventilation. Following approval by the local Ethics Committees and written informed consent, 118 (29-30 at each center) patients presenting for elective surgery under total intravenous anesthesia were included. Patients were ASA I/II, Mallampati I/II, aged 18-65 yrs with a BMI < 30 kg/m2. Propofol was used for induction (2.5 mg/kg) and maintenance (12 mg/kg/hr propofol) of anesthesia along with a choice of narcotic agent. Patients were ventilated with intermittent positive pressure ventilation, a respiratory rate of 12/min, an inspiratory/expiratory ratio of 1:2, a fresh gas flow of 3 L/min in order to maintain CO2 < 45 mmHg and SpO2 ≥ 95%. Data was collected on size of device, number of insertion attempts, cuff inflation, and oropharyngeal leak pressures. The position of the Ambu Laryngeal Mask was confirmed with fiberoptic endoscopy and the view recorded. Assessment of the position was done using the following scoring system: 4, only cords seen; 3, cords plus posterior epiglottis; 2, cords plus anterior epiglottis; 1, cords not seen, but function adequate; 0, failure to function where cords not seen fiberoptically.3 Perioperative and postoperative complications were noted. Patients were examined for sore throat, dysphonia, and dysphagia 1 hr and 24 hrs postoperatively. Demographically, patients were 42.8±13.97 yrs of age (60.2% female, 39.8% male), 171.2±8.30 cm in height, with a BMI of 24.5±3.11 kg/m2 and Mallampati grade I/II (62.9%/37.1%) Patients received a size 3 (0.8%), 4 (51.7%), or 5 (47.5%) Ambu Laryngeal Mask, according to manufacturer’s recommendations. The cuff pressure was adjusted to 60 cm H2O. Duration of surgery was 67.4±41.89 mins (25-250 mins). All patients were successfully intubated on the first or second attempt (92.4% and 7.6%, respectively) with an insertion time of 44.9±37.91 sec. Oropharyngeal leak pressures were 24.1±5.44 cm H2O. The vocal cords could be visualized by fiberoptic endoscopy in 91.5% patients and adequate ventilation was achieved in all patients. Complications included blood on the device (8.5%), bucking during removal (0.8%), and minor trauma to the tongue (0.8%), or lips (0.8%). Postoperative complaints 1hr after surgery were sore throat (mild-5.1%, moderate-1.7%), dysphonia (mild-0.8%), dysphagia (mild-2.5%, moderate-1.7%). For complaints 24 hrs after surgery, only mild sore throat (2.2%) and mild dysphonia (1.1%) remained. C. Hagberg1, F. Jensen2, H. Genzwurker3, R. Krivosic-Horber4, B. Schmitz1, H. Menu4, and C. Vogt-Harenkamp1 1University of Texas Medical School at Houston, Houston, TX, 2Amtssygehuset i Gentofte, Hellerup, Denmark, 3University Hospital of Mannheim, Mannheim, Germany, 4Hopital Roger Salengro, Lille Cedex, France. DISCUSSION In anesthetized, non-paralyzed patients, the Ambu Laryngeal Mask is easy and quick to insert. It forms a safe and efficient seal during positive pressure ventilation. Further studies are warranted. Figure 1: Ambu Laryngeal Mask REFERENCES • Verghese C, Brimacombe JR: Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg 1996;82:129-33. • Benumof JL:Laryngeal Mask Airway and the ASA Difficult Airway Algorithm. Anesthesiology 1996;84:686-99. • Keller C, Brimacombe J, Puehringer F. A fibreoptic scoring system to assess the position of laryngeal mask airway devices: Interobserver variability and a comparison between the standard, flexible and intubation laryngeal airways. Anasthesiol Intensivmed Notfallmed Schmerzther 2000; 35:692-4.

More Related